COVID-19 vaccine makers cannot be sued for injuries or deaths caused by their product.f1] Victims· may file .a claim with the federal Countermeasures Injury Compensatic Prograrn (ClCP}; but as yet, there is no Table of Covered Injuries for COVID-19 vaccines. Outcomes for past claims for other produc'ts fan to inspire confidence - since 2010, a \.Vhopping 92% of claims filed with CICP were rejected, with no appeal permitted. [21[~

The recent FDA authorization for COVID~ 19 vaccines is for E1nergency Use A.uthoriz~tion ONLY,.Testing for th ese vaccines was not t required to meet standards otherwise :required by federal law for FDA approval. According to the FDA, "There is no U.SB food and Drug Administration (FDA) approv辺 vaccine 'to prevent COVID-19." [4

R唄hing a questionable vaccine into.public. use has fatally b~ckfired before讜 A similar hurried vaccine ronout led to the death of numerous Filipino children who received a dengue vaccine during a declared epidemic, before iong-tern1 risl<s V\Jere understood. [6] No one yet knows how the new COVID-19 vaccines wm affect people with autoim111une disease1 peep.le vvith cancer, pregnant women and unborn bab~es, or what impa~t the vaccine may have on fertility.

n1RNA is still an unproven technology, never before used in vaccines for humans.[7] Previous coronavirus 111RNA vaccine trials resulted in ferrets with liver damage,[8] mice with ent;anced respiratory disease,[9] and monkeys with ADE lung damage. [10]

CurrentCOV巴19 vaccines have not proven to prevent disease transmission5[11] [12] They may reduce symptoms without preventing infection.

[[1] https://wvvw.phe.gov/Preparedness/legal/prnpact/Pages/default.aspx 罔 https://www.hrsa.gov/cicp/fi!ing-bene戩S

{3J https:/ /www.rnctlaw.com/vaccine-injury /vaccinations/coronavirus-covid-19 !4! https:/ /www.fda.gov/media/144412/dow函ad

[51 https://wv-lW.fda.gov/rnedia/144414/downroad

--'` ~ · ~

i ．這氙［商灶頴臣這？ 「 -

[6] https://11\'\'I/W.sciencemag.org/ne昞rs/2019/04/dengue-vaccine-fiasco-leads-criminal-charges-researc區r-phi!ipp咩S

囝 https://www.fastcompany.com/90573488/l1ow-pfizers心ovld-19-vaccine-worl<s-mma

{BJ https:/!\<\rww.ncbi.nlm.nih.gov/pmc/artic!es/PMC7115540/. [9lhttps:IIwww.ncbinlm.nih.gov/pmc/articles/PMC1716185/ [1O]https;/ fwm,WJ1cbi.n!m.nih.gov/pmc/ar"ticles/PMC7075522/ 向 https://\.'lfWW.cdc.gov/coro區virus/201鉭1cov/vaccines/faq.htn、l

図 https:lIw硒 1^11.n西mes.com/2020/11/17/hea!th/coronavirus--immunity.h际I tm6cmm詛3d『譌哂怠弇四d2^ ` '̀

差： DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service

SENT VIA EMAIL

Elizabeth Brehm Siri & Glimstad 200 Park A venue, 17th Floor New York, 10166 Via email: foia@sirillp.com

Dear Ms. Brehm:

Centers for Disease Control and Prevention (CDC)

Atlanta GA 30333

July 29, 2020

This letter is in response to your Centers for Disease Control and Prevention and Agency for Toxic Substances and Disease Registry (CDC/ATSDR) Freedom oflnformation Act (FOIA) request of July 13, 2020, for:

"All docume~ts in the CDC's possesston which compare the ~ealth outcomes betwee9 children that have received: vaccines and children that have never received'any vaccines." :

A search of our records failed to reveal any documents pertaining to your request. The CDC has not conducted a study of health outcomes in vaccinated vs unvaccinated populations.

You may contact our ·FOIA Public Liaison at 770-488-6277 for any further assistance and to discuss any aspect of your request. Additionally, you may contact the Office of q-overnment Information: Services (OGIS) at the National Archives and Records Administration to inquire about the FOIA mediation services they offer. The contact information for OGIS is as follows: Office of Government Information Services, National Archives and Records Administration, 8601 Adelphi Road-OGIS, College Park, Maryland 20740-6001, e-mail at ogis@nara.gov; telephone at 202-741-5770; toll free at 1-877-684-6448; or facsimile at 202-741-5769. I

If you are not satisfied with the response to this request, you may administratively appeal by writing to the Deputy Agency ChiefFOIA Officer, Office of the Assistant Secretary for Public Affairs, U.S. Department of Health and Human Services, Hubert H. Humphrey Building, 200 Independence A venue, Suite 729H, Washington, D.C. 20201. You may also transmit your appeal via email to~-Please mark both your appeal letter and envelope "FOIA Appeal." Your唧eal must be postmarked or electronically transmitted by November 2, 2020.

#20-02002-FOIA

Sincerely,

Roger Andoh CDC/ ATSDR FOIA Officer Office of the Chief Operating Officer Phone: (770) 488-6399 Fax: (404) 235-1852